Neurology
Found 46 results
Filters: Author is Gauthier, Susan A and Keyword is Humans  [Clear All Filters]
2023
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)
2022
Cho J, Nguyen TD, Huang W, Sweeney EM, Luo X, Kovanlikaya I, Zhang S, Gillen KM, Spincemaille P, Gupta A et al..  2022.  Brain oxygen extraction fraction mapping in patients with multiple sclerosis.. J Cereb Blood Flow Metab. 42(2):338-348.
Longbrake EE, Hua LH, Mowry EM, Gauthier SA, Alvarez E, Cross AH, Pei J, Priest J, Raposo C, Hafler DA et al..  2022.  The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.. Mult Scler Relat Disord. 68:104143.
Li J, Huang W, Luo X, Wen Y, Cho J, Kovanlikaya I, Gauthier SA, Nguyen TD, Spincemaille P, Wang Y.  2022.  The central vein sign in multiple sclerosis lesions: Susceptibility relaxation optimization from a routine MRI multiecho gradient echo sequence.. J Neuroimaging. 32(1):48-56.
Zinger N, Ponath G, Sweeney E, Nguyen TD, Lo CHung, Diaz I, Dimov A, Teng L, Zexter L, Comunale J et al..  2022.  Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions.. Neurol Neuroimmunol Neuroinflamm. 9(2)
Marcille M, Rúa SHurtado, Tyshkov C, Jaywant A, Comunale J, Kaunzner UW, Nealon N, Perumal JS, Zexter L, Zinger N et al..  2022.  Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis.. Sci Rep. 12(1):4411.
Dimov AV, Nguyen TD, Spincemaille P, Sweeney EM, Zinger N, Kovanlikaya I, Kopell BH, Gauthier SA, Wang Y.  2022.  Global cerebrospinal fluid as a zero-reference regularization for brain quantitative susceptibility mapping.. J Neuroimaging. 32(1):141-147.
Rúa SMHurtado, Kaunzner UW, Pandya S, Sweeney E, Tozlu C, Kuceyeski A, Nguyen TD, Gauthier SA.  2022.  Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients.. Eur J Neurol. 29(1):237-246.
Dimov AV, Gillen KM, Nguyen TD, Kang J, Sharma R, Pitt D, Gauthier SA, Wang Y.  2022.  Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation.. Tomography. 8(3):1544-1551.
Zhang H, Nguyen TD, Zhang J, Marcille M, Spincemaille P, Wang Y, Gauthier SA, Sweeney EM.  2022.  QSMRim-Net: Imbalance-aware learning for identification of chronic active multiple sclerosis lesions on quantitative susceptibility maps.. Neuroimage Clin. 34:102979.
Huang W, Sweeney EM, Kaunzner UW, Wang Y, Gauthier SA, Nguyen TD.  2022.  Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination.. J Neuroimaging. 32(4):667-675.
Kim J, Nguyen TD, Zhang J, Gauthier SA, Marcille M, Zhang H, Cho J, Spincemaille P, Wang Y.  2022.  Subsecond accurate myelin water fraction reconstruction from FAST-T data with 3D UNET.. Magn Reson Med. 87(6):2979-2988.
Dimov AV, Nguyen TD, Gillen KM, Marcille M, Spincemaille P, Pitt D, Gauthier SA, Wang Y.  2022.  Susceptibility source separation from gradient echo data using magnitude decay modeling.. J Neuroimaging. 32(5):852-859.
Pitt D, Lo CHung, Gauthier SA, Hickman RA, Longbrake E, Airas LM, Mao-Draayer Y, Riley C, De Jager PLawrence, Wesley S et al..  2022.  Toward Precision Phenotyping of Multiple Sclerosis.. Neurol Neuroimmunol Neuroinflamm. 9(6)
2021
Zhang H, Zhang J, Li C, Sweeney EM, Spincemaille P, Nguyen TD, Gauthier SA, Wang Y, Marcille M.  2021.  ALL-Net: Anatomical information lesion-wise loss function integrated into neural network for multiple sclerosis lesion segmentation.. Neuroimage Clin. 32:102854.
Ontaneda D, Raza PC, Mahajan KR, Arnold DL, Dwyer MG, Gauthier SA, Greve DN, Harrison DM, Henry RG, Li DKB et al..  2021.  Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement.. Brain. 144(7):1974-1984.
Tozlu C, Jamison K, Gu Z, Gauthier SA, Kuceyeski A.  2021.  Estimated connectivity networks outperform observed connectivity networks when classifying people with multiple sclerosis into disability groups.. Neuroimage Clin. 32:102827.
Sweeney EM, Nguyen TD, Kuceyeski A, Ryan SM, Zhang S, Zexter L, Wang Y, Gauthier SA.  2021.  Estimation of Multiple Sclerosis lesion age on magnetic resonance imaging.. Neuroimage. 225:117451.
Gillen KM, Mubarak M, Park C, Ponath G, Zhang S, Dimov A, Levine-Ritterman M, Toro S, Huang W, Amici S et al..  2021.  QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions.. Ann Clin Transl Neurol. 8(4):877-886.
2020
Bagnato F, Gauthier SA, Laule C, Moore GRWayne, Bove R, Cai Z, Cohen-Adad J, Harrison DM, Klawiter EC, Morrow SA et al..  2020.  Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy.. J Neuroimaging. 30(3):251-266.
2019
Kang Y, Gauthier SA.  2019.  PET is necessary to make the next step forward in understanding MS pathophysiology - Commentary.. Mult Scler. 25(8):1090-1091.
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.
2018
Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.  2018.  Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.. PLoS One. 13(8):e0201289.
Zhang S, Nguyen TD, Zhao Y, Gauthier SA, Wang Y, Gupta A.  2018.  Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions.. Neuroimage Clin. 18:143-148.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.